Summit Therapeutics
SMMT
C$37.71
Share price
-4.26%
Change (1 day)
152.46%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: C$28.00 Billion
As of July 2025 Summit Therapeutics has a market cap of C$28.00 Billion. This makes Summit Therapeutics the world's 1047th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | C$28.00 B | 45.33% |
| 2024 | C$19.27 B | 694.27% |
| 2023 | C$2.42 B | 108.97% |
| 2022 | C$1.16 B | 246.59% |
| 2021 | C$0.33 B | -32.05% |
| 2020 | C$0.49 B | 251.16% |
| 2019 | C$0.14 B | 444.66% |
| 2018 | C$25.77 M | -87.6% |
| 2017 | C$0.20 B | 46.99% |
| 2016 | C$0.14 B | -27.66% |
| 2015 | C$0.19 B |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Summit Therapeutics was reported to be:
C$28.00 Billion
C$28.00 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | C$1.87 B | -93.32% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | C$8.46 B | -69.76% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | C$0.30 B | -98.90% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | C$0.17 B | -99.39% | 🇺🇸 USA |